ANI Pharmaceuticals, Inc. (ANIP) |
| 78.37 0.72 (0.93%) 07-27 16:00 |
| Open: | 77.72 |
| High: | 79.119 |
| Low: | 77.72 |
| Volume: | 343,152 |
| Market Cap: | 1,782(M) |
| PE Ratio: | 9.53 |
| Exchange: | NASDAQ |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 87.19 |
| Resistance 1: | 83.08 |
| Pivot price: | 80.61 |
| Support 1: | 76.43 |
| Support 2: | 63.59 |
| 52w High: | 99.5 |
| 52w Low: | 62.61 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| EPS | 3.910 |
| Book Value | 26.340 |
| PEG Ratio | 0.00 |
| Gross Profit | 24.718 |
| Profit Margin (%) | 9.98 |
| Operating Margin (%) | 16.30 |
| Return on Assets (ttm) | 5.0 |
| Return on Equity (ttm) | 18.3 |
Mon, 27 Jul 2026
ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mon, 27 Jul 2026
BlackRock (ANIP) discloses 2.9M-share, 12.8% stake in ANI Pharmaceuticals - Stock Titan
Mon, 27 Jul 2026
ANI Pharmaceuticals Inc (ANIP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mon, 27 Jul 2026
ANI Pharmaceuticals Inc (ANIP) Cash Flow - TradingKey
Sun, 26 Jul 2026
ANI Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:ANIP - TradingView
Sat, 25 Jul 2026
Is ANI Pharmaceuticals (ANIP) A Bargain Following Its Positive SYNCHRONICITY Trial Results? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |